Kevin Davies is a scientific editor, author and publisher. 25 years after establishing Nature Genetics as the founding editor, he launched The CRISPR Journal, a new peer-review journal on gene editing (published by Mary Ann Liebert Inc.) He has also served as editor-in-chief of Cell Press and publisher of Chemical & Engineering News. Kevin is the author of several popular science books including Cracking the Genome and The $1,000 Genome. Last year he joined Jim Watson and Andrew Berry as a co-author of DNA: The Story of the Genetic Revolution. He is also the recipient of a 2017 Guggenheim Foundation Fellowship and is working on a new book on genome editing.
Kevin graduated with a degree in biochemistry from Oxford University and obtained his PhD in human genetics from St Mary’s Hospital Medical School in London. After a pair of postdoctoral fellowships at MIT and Harvard Medical School, he retired from the bench, landing a position as genetics editor for Nature magazine.
The CRISPR Revolution: From Reading to Editing Genomes
Fifteen years ago, scientists celebrated the completion of the Human Genome Project, ahead of schedule and under budget. Over the next decade, advances in next-generation DNA sequencing have slashed the cost of genome sequencing from millions of dollars to the vaunted $1,000 genome. The ubiquity of rapid genome sequencing has major ramifications for basic research and clinical medicine, especially in pediatrics and cancer. With these remarkable improvements in reading DNA sequencing, we are entering a new era in which scientists can write and edit genome sequences almost at will. British author and science editor Kevin Davies has written extensively about advances in genome research and medicine over the past two decades. In his role as founding Executive Editor of The CRISPR Journal, he trains his sights on the revolution in genome editing, and specially CRISPR. He will reflect on the brief history of CRISPR research and discuss some of the exciting and controversial areas it is likely to impact in the years ahead.